These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30394006)

  • 1. Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial.
    Mason SA; Rasmussen B; van Loon LJC; Salmon J; Wadley GD
    Diabetes Obes Metab; 2019 Mar; 21(3):674-682. PubMed ID: 30394006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes.
    Jones KL; Rigda RS; Buttfield MDM; Hatzinikolas S; Pham HT; Marathe CS; Wu T; Lange K; Trahair LG; Rayner CK; Horowitz M
    Diabetes Obes Metab; 2019 May; 21(5):1158-1167. PubMed ID: 30623563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium and ascorbic acid supplementation in diabetes mellitus.
    Eriksson J; Kohvakka A
    Ann Nutr Metab; 1995; 39(4):217-23. PubMed ID: 8546437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid supplementation improves skeletal muscle oxidative stress and insulin sensitivity in people with type 2 diabetes: Findings of a randomized controlled study.
    Mason SA; Della Gatta PA; Snow RJ; Russell AP; Wadley GD
    Free Radic Biol Med; 2016 Apr; 93():227-38. PubMed ID: 26774673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial.
    Monteyne AJ; Falkenhain K; Whelehan G; Neudorf H; Abdelrahman DR; Murton AJ; Wall BT; Stephens FB; Little JP
    Diabetologia; 2024 Jun; 67(6):1107-1113. PubMed ID: 38483543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
    Flint A; Kapitza C; Hindsberger C; Zdravkovic M
    Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes.
    Trahair LG; Horowitz M; Stevens JE; Feinle-Bisset C; Standfield S; Piscitelli D; Rayner CK; Deane AM; Jones KL
    Diabetologia; 2015 Aug; 58(8):1769-78. PubMed ID: 26048234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: A double-blind, randomized, controlled, acute feeding, equivalence trial.
    Noronha JC; Braunstein CR; Glenn AJ; Khan TA; Viguiliouk E; Noseworthy R; Blanco Mejia S; Kendall CWC; Wolever TMS; Leiter LA; Sievenpiper JL
    Diabetes Obes Metab; 2018 Oct; 20(10):2361-2370. PubMed ID: 29797503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
    Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients.
    Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Diamant M; van Raalte DH
    Diabetes Res Clin Pract; 2017 Feb; 124():1-10. PubMed ID: 28086201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
    Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.
    Hodgson JM; Watts GF; Playford DA; Burke V; Croft KD
    Eur J Clin Nutr; 2002 Nov; 56(11):1137-42. PubMed ID: 12428181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
    Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
    Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study.
    Reynolds AN; Mann JI; Williams S; Venn BJ
    Diabetologia; 2016 Dec; 59(12):2572-2578. PubMed ID: 27747394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial.
    Tsaban G; Aharon-Hananel G; Shalem S; Zelicha H; Yaskolka Meir A; Pachter D; Goldberg DT; Kamer O; Alufer L; Stampfer MJ; Wang DD; Qi L; Blüher M; Stumvoll M; Hu FB; Shai I; Tirosh A
    Diabetes Obes Metab; 2024 Oct; 26(10):4713-4723. PubMed ID: 39134456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.